• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Topics Engaged In

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Aug 19
8:00 am - 9:00 am EDT

Member Forum: Equitable Access to Care

Aug 19
6:00 pm - 7:00 pm EDT

Member Forum: Equitable Access to Care

Aug 20
11:00 am - 12:00 pm EDT

ALS-FTD Clinicopathological Overlap

Sep 8
8:00 am - 9:00 am EDT

Member Forum: Health Literacy

Sep 8
6:00 pm - 7:00 pm EDT

Member Forum: Health Literacy

View Calendar

  • Ali Var, Turkey

    Ali Var, Turkey

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • John Russo, USA

    John Russo, USA
    final3878

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Len Johnrose, England

    Len Johnrose, England

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Anna Barrow, UK

    Anna Barrow, UK

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Timmy, Belgium

    Timmy, Belgium

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Bob Simonds, USA

    Bob Simonds, USA

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Brian Parsons, Canada

    Brian Parsons, Canada

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Purningam Jacob, India

    Purningam Jacob, India

  • Liam Dwyer, England

    Liam Dwyer, England

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Jean

    Jean
    jean

  • Ian Gale, Australia

    Ian Gale, Australia

  • Liam Dwyer, England

    Liam Dwyer, England

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login